$LIFE

Ethos Technologies Inc.

No enriched coverage for $LIFE in the last 7 days.

—
$9.1M
Colis Peter George
100%
See all $LIFE insider activity →
Low

Wang Lingke sold $4.5M of LIFE

Wang Lingke (President) sold 118,333 shares of Ethos Technologies Inc. (LIFE) at an average of $38.36 ($37.64–$39.14, $4.54M total) across 3 trades on 2026-10-15 under a Rule 10b5-1 trading plan.

Colis Peter George sold $4.6M of LIFE

Colis Peter George (CEO and Secretary) sold 120,000 shares of Ethos Technologies Inc. (LIFE) at an average of $38.39 ($37.64–$39.58, $4.61M total) across 7 trades over 2026-10-14 to 2026-10-16 under a Rule 10b5-1 trading plan.

LIFE sentiment & insider activity

Recent LIFE coverage spans insider activity, financial news and earnings.

In the last 30 days, LIFE insiders filed 10 SEC Form 4 transactions — no purchases and 10 sales ($9.1M). The most active reporter was Colis Peter George, CEO and Secretary, with 7 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving LIFE

AlphAI scores every news story that mentions LIFE with an AI model for sentiment and relevance, and aggregates insider trades from Ethos Technologies Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $LIFE

Score

Ethos Technologies Inc. is providing the below beneficial ownership table to provide updated information regarding the beneficial ownership of shares of the…

Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. Ethos Technologies Inc. (the “Company”) is providing the below beneficial ownership table to provide updated information regarding the beneficial ownership of shares of the Company’s Class A common stock, $0.0001 par value (the “Class A common stock”) and

$XOMMed

This ExxonMobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Analysts downgraded several stocks: BTIG cut Liquidia (LQDA) to Neutral, BMO reduced Sigma Lithium (SGML) to Market Perform with a $10 target, Wells Fargo downgraded ExxonMobil (XOM) to Equal-Weight with a $182 target, UBS lowered Ormat (ORA) to Neutral with a $100 target, and JP Morgan changed Ethos (LIFE) to Neutral. Prices as of Wednesday's close: LQDA $30.26, SGML $9.40, XOM $162.75, ORA $91.49, LIFE $33.57.

$BPLow

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP, Dollar Tree, Exxon Mobil, Lennar, Occidental Petroleum, Rocket Lab, Teva Pharmaceuticals, United Therapeutics, and More

Wall Street analysts issued updates on various companies. BP (NYSE: BP) was upgraded to Overweight with a $71 target, Dollar Tree (NASDAQ: DLTR) to Buy with a $140 target, and Occidental Petroleum (NYSE: OXY) to Buy with a $69 target. Exxon Mobil (NYSE: XOM) was downgraded to Equal Weight with an $182 target. Other notable initiations and changes include Lennar (NYSE: LEN), Rocket Lab (NASDAQ: RKLB), Teva Pharmaceuticals (NASDAQ: TEVA), and more.

Related tickers